# Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)

> **NCT02584439** · PHASE3 · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 20 (actual)

## Conditions studied

- Healthy
- Vascular Stiffness
- Aging

## Interventions

- **DRUG:** ivabradine
- **DRUG:** lactose capsule (placebo)

## Key facts

- **NCT ID:** NCT02584439
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-03
- **Primary completion:** 2019-07-15
- **Final completion:** 2019-07-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02584439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02584439, "Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT02584439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*